Skip to main content

Movers & Shakers: Jul 23, 2009

Premium

Gilbert Omenn has been named to the scientific advisory board of Pro-Pharmaceuticals, the company said last week.

Ommen, a professor of internal medicine, human genetics, and public health at the University of Michigan where he is also director of the Center for Computational Medicine and Bioinformatics. He is vice president of the Human Proteome Organization and chair of HUPO Initiatives as well as chair of HUPO's Human Plasma Proteome Project.

Newton, Mass.-based Pro-Pharmaceuticals discovers, develops, and commercializes carbohydrate therapeutics for cancer and fibrosis.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.